Asklepios BioPharmaceutical

1 follower

‌

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.

Industries

Biotechnology, Health Care

Headquarters

Chapel Hill, United States

Employees

51-200

Links

Org chart

Gustavo Pesquin

CEO

Gustavo Pesquin

Collapse

R. Jude Samulski

President, Chief Scientific Officer & Co-Founder

Canwen Jiang

Chief Development Officer & CMO

Josh Grieger

CTO

Candace Summerford

Chief Patent Officer

Tracy Dowling

General Counsel & Head of Business Development

Mansuo L Shannon

Board Member

Melissa Murrell

Chief People Officer

Teams

Leadership Team

4 members

Business Development and Strategy

5 members

Clinical Operations

3 members

Regulatory and Quality Assurance

3 members

Similar companies

Owkin

4 followers

Stemline Therapeutics

3 followers

Xilio Therapeutics

2 followers

Merck

214 followers

Garuda Therapeutics

4 followers

Relay Therapeutics

1 follower

Volastra

1 follower

Poppi

10 followers

Grow Therapy

2 followers

Belle

5 followers

cGMP Validation LLC

1 follower

Explore companies